Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Expenditures (2016 - 2025)

Phibro Animal Health has reported Capital Expenditures over the past 13 years, most recently at $11.1 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $11.1 million for Q4 2025, up 41.87% from a year ago — trailing twelve months through Dec 2025 was $45.8 million (up 3324.91% YoY), and the annual figure for FY2025 was $38.3 million, up 1517.79%.
  • Capital Expenditures for Q4 2025 was $11.1 million at Phibro Animal Health, down from $13.8 million in the prior quarter.
  • Over the last five years, Capital Expenditures for PAHC hit a ceiling of $23.2 million in Q3 2022 and a floor of -$38.1 million in Q2 2023.
  • Median Capital Expenditures over the past 5 years was $7.9 million (2023), compared with a mean of $4.3 million.
  • Peak annual rise in Capital Expenditures hit 211.13% in 2022, while the deepest fall reached 412.95% in 2022.
  • Phibro Animal Health's Capital Expenditures stood at $7.7 million in 2021, then grew by 27.69% to $9.8 million in 2022, then increased by 11.61% to $11.0 million in 2023, then dropped by 28.62% to $7.8 million in 2024, then surged by 41.87% to $11.1 million in 2025.
  • The last three reported values for Capital Expenditures were $11.1 million (Q4 2025), $13.8 million (Q3 2025), and $13.1 million (Q2 2025) per Business Quant data.